| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 200 |
-
|
-
|
-
| | Cost of Revenue | (1,478) | 797 | 681 | 1,277 | | | Gross Profit | 1,678 | (797) | (681) | (1,277) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (472) | 1,410 | 514 | (1,367) | | Non Recurring | 2,596 |
-
| 10 | (1,102) | | Others | 23 | 24 | 23 | 23 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (469) | (2,231) | (1,228) | 1,169 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 143 | 498 | 575 | (1,987) | | Earnings Before Interest And Taxes | (326) | (1,733) | (653) | (818) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (326) | (1,733) | (653) | (818) | | Income Tax Expense | 204 | (295) | 84 | 124 | | Minority Interest | 153 | 50 | 66 | 54 | | | | Net Income From Continuing Ops | (377) | (1,388) | (671) | (888) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (377) | (1,388) | (671) | (888) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($377) | ($1,388) | ($671) | ($888) |
|
1.17% Nasdaq 
Income Statement
